Straits Times Index
3,292.69 +10.64 (+0.32%) S&P 500
5,018.61 -17.08 (-0.34%) Dow
37,917.75 +101.83 (+0.27%) Nasdaq
15,580.11 -77.71 (-0.50%) Bitcoin USD
56,873.59 -3,720.44 (-6.14%) CMC Crypto 200
1,186.84 -152.23 (-11.37%)
CVS May 2024 67.000 call
| Previous close | 2.3400 |
| Open | 0.0100 |
| Bid | 0.0100 |
| Ask | 0.0800 |
| Strike | 67.00 |
| Expiry date | 2024-05-10 |
| Day's range | 0.0100 - 0.1000 |
| Contract range | N/A |
| Volume | |
| Open interest | 105 |
- Yahoo Finance Video
CVS stock falls on weak outlook, Q1 miss
Shares of CVS Health (CVS) are falling during Wednesday's trading session after the company revised its full-year guidance downward, citing mounting pressure from rising medical costs. The adjustment to the company's guidance comes on the heels of CVS's weaker-than-expected first quarter results, which missed estimates for both revenue and earnings. Yahoo Finance's Anjalee Khemlani breaks down the report. For more expert insight and the latest market action, click here to watch this full episode of Morning Brief. This post was written by Angel Smith
- Yahoo Finance Video
Fed rate decision, Qualcomm earnings: What to Watch
Market Domination Overtime anchors Julie Hyman and Josh Lipton preview the top headlines for investors for tomorrow, Wednesday, May 1, 2024. Federal Reserve officials will issue their latest interest rate policy decision coming out of their FOMC meeting tomorrow afternoon, followed by a press conference by Fed Chair Jerome Powell. On the earnings front, a slew of companies are set to release quarterly reports, including names like DoorDash (DASH), Mastercard (MA), and Qualcomm (QCOM). For more expert insight and the latest market action, click here to watch this full episode of Market Domination Overtime. This post was written by Angel Smith
BenzingaRising Cost For Health Insurers Bites CVS Health's Q1 Profit, Stock Tanks
On Wednesday, CVS Health Corp (NYSE:CVS) reported first-quarter sales of $88.4 billion, up 3.7% year over year, missing the consensus of $89.21 billion. This was largely due to strong growth in the Health Care Benefits and Pharmacy and consumer Wellness segments, partially offset by a decline in the Health Services segment. Adjusted EPS of $1.31 decreased from $2.20 in the prior year, missing the consensus of $1.69, primarily due to a decline in the Health Care Benefits segment’s operating resul
